Life Science

The less predominant-occurring (~20%) stereoisomer of the endogenous oxysterol 27-hydroxy cholesterol.

The less predominant-occurring (~20%) stereoisomer of the endogenous oxysterol 27-hydroxy cholesterol.

A side-chain substituted oxysterol derived from dietary cholesterol that inhibits the cleavage of SREBPs has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis as well as antitumor and

A side-chain substituted oxysterol derived from dietary cholesterol that inhibits the cleavage of SREBPs has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis as well as antitumor and

A side-chain substituted oxysterol derived from dietary cholesterol that inhibits the cleavage of SREBPs has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis as well as antitumor and

A side-chain substituted oxysterol derived from dietary cholesterol that inhibits the cleavage of SREBPs has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis as well as antitumor and

An internal standard for the quantification of 25-hydroxy cholesterol by GC- or LC-MS.

An internal standard for the quantification of 25-hydroxy cholesterol by GC- or LC-MS.

An internal standard for the quantification of 25-hydroxy cholesterol by GC- or LC-MS.

An intermediate produced from vitamin D2 by cytochrome P450 isoforms in vertebrates subsequently metabolized to 1,25-dihydroxy vitamin D2, which is an agonist for the vitamin D receptor.

An intermediate produced from vitamin D2 by cytochrome P450 isoforms in vertebrates subsequently metabolized to 1,25-dihydroxy vitamin D2, which is an agonist for the vitamin D receptor.

An intermediate produced from vitamin D2 by cytochrome P450 isoforms in vertebrates subsequently metabolized to 1,25-dihydroxy vitamin D2, which is an agonist for the vitamin D receptor.